Matthew Plunkett
2012 - CTI BioPharma
In 2012, Matthew Plunkett earned a total compensation of $321.5K as Executive Vice President, Corporate Development at CTI BioPharma.
Compensation breakdown
| Bonus | $62,500 |
|---|---|
| Salary | $106,041 |
| Stock Awards | $153,000 |
| Total | $321,541 |
Plunkett received $153K in stock awards, accounting for 48% of the total pay in 2012.
Plunkett also received $62.5K in bonus and $106K in salary.
Rankings
In 2012, Matthew Plunkett's compensation ranked 9,975th out of 11,487 executives tracked by ExecPay. In other words, Plunkett earned more than 13.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,975 out of 11,487 | 13th |
Division Manufacturing | 3,699 out of 4,253 | 13th |
Major group Chemicals And Allied Products | 1,032 out of 1,198 | 14th |
Industry group Drugs | 785 out of 920 | 15th |
Industry Pharmaceutical Preparations | 599 out of 700 | 14th |
Source: SEC filing on July 29, 2015.
Plunkett's colleagues
We found seven more compensation records of executives who worked with Matthew Plunkett at CTI BioPharma in 2012.
2012
James Bianco
CTI BioPharma
Chief Executive Officer
2012
Craig Philips
CTI BioPharma
Former President
2012
Jack Singer
CTI BioPharma
Chief Scientific Officer
2012
Louis Bianco
CTI BioPharma
Executive Vice President, Finance and Administration
2012
Daniel Eramian
CTI BioPharma
Former Executive Vice President Corporate Communications
2012
Steven Benner
CTI BioPharma
Chief Medical Officer
2012
Translational Benner
CTI BioPharma